BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 23434274)

  • 1. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression.
    Gui D; Huang J; Guo Y; Chen J; Chen Y; Xiao W; Liu X; Wang N
    Cytokine; 2013 Mar; 61(3):970-7. PubMed ID: 23434274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV prevents kidney injury caused by iatrogenic hyperinsulinemia in a streptozotocin‑induced diabetic rat model.
    He KQ; Li WZ; Chai XQ; Yin YY; Jiang Y; Li WP
    Int J Mol Med; 2018 Feb; 41(2):1078-1088. PubMed ID: 29207011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation.
    Zhang Y; Tao C; Xuan C; Jiang J; Cao W
    Oxid Med Cell Longev; 2020; 2020():9542165. PubMed ID: 32855769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat.
    Lu HJ; Tzeng TF; Liou SS; Da Lin S; Wu MC; Liu IM
    BMC Complement Altern Med; 2014 Mar; 14():110. PubMed ID: 24666993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
    BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.
    Tone A; Shikata K; Sasaki M; Ohga S; Yozai K; Nishishita S; Usui H; Nagase R; Ogawa D; Okada S; Shikata Y; Wada J; Makino H
    Diabetologia; 2005 Nov; 48(11):2402-11. PubMed ID: 16231067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway.
    Leng B; Tang F; Lu M; Zhang Z; Wang H; Zhang Y
    Life Sci; 2018 Sep; 209():111-121. PubMed ID: 30081006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of ginsenoside Rgl on the expression of TNF-alpha and MCP-1 in rats with diabetic nephropathy].
    Zhang LN; Xie XS; Zuo C; Fan JM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):466-71. PubMed ID: 19627007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of PERK-ATF4-CHOP pathway by Astragaloside IV is associated with the inhibition of endoplasmic reticulum stress-induced podocyte apoptosis in diabetic rats.
    Chen Y; Gui D; Chen J; He D; Luo Y; Wang N
    Cell Physiol Biochem; 2014; 33(6):1975-87. PubMed ID: 25012492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
    Ohga S; Shikata K; Yozai K; Okada S; Ogawa D; Usui H; Wada J; Shikata Y; Makino H
    Am J Physiol Renal Physiol; 2007 Apr; 292(4):F1141-50. PubMed ID: 17190910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
    Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
    Yu WM; Wang H; Ren XJ; Liu JP; Wang JY
    Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics.
    Zhang H; Zhao T; Gong Y; Dong X; Zhang W; Sun S; Wang H; Gu Y; Lu X; Yan M; Li P
    J Ethnopharmacol; 2014; 151(1):556-64. PubMed ID: 24269779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats.
    Wang F; Li M; Cheng L; Zhang T; Hu J; Cao M; Zhao J; Guo R; Gao L; Zhang X
    Life Sci; 2008 Dec; 83(25-26):828-35. PubMed ID: 18983856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro.
    Zhou X; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q
    Int Immunopharmacol; 2017 Jan; 42():18-24. PubMed ID: 27855303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
    Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy.
    Guo H; Wang Y; Zhang X; Zang Y; Zhang Y; Wang L; Wang H; Wang Y; Cao A; Peng W
    Sci Rep; 2017 Jul; 7(1):6852. PubMed ID: 28761152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway.
    Guo M; Gao J; Jiang L; Dai Y
    Drug Des Devel Ther; 2023; 17():2107-2118. PubMed ID: 37489175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
    Zhu L; Han J; Yuan R; Xue L; Pang W
    Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.